Interleukin 10 (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Interleukin 10" in Malay language version.

refsWebsite

Global rank Malay rank

4^th place

14^th place

2^nd place

8^th place

18^th place

46^th place

5^th place

23^rd place

low place

low place

1,626^th place

2,173^rd place

low place

low place

1sciencedirect.com

149^th place

354^th place

1,538^th place

1,157^th place

3,518^th place

2,322^nd place

1web.archive.org

1^st place

1^st place

low place

low place

1immuno-oncologynews.com

low place

low place

ascopubs.org

hwmaint.meeting.ascopubs.org

Infante, Jeffrey R.; Naing, Aung; Papadopoulos, Kyriakos P.; Autio, Karen A.; Ott, Patrick Alexander; Wong, Deborah Jean Lee; Falchook, Gerald Steven; Patel, Manish R.; Pant, Shubham (2015-05-20). "A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors". ASCO Meeting Abstracts. 33 (15_suppl): 3017. Diarkibkan daripada yang asal pada 2015-12-22. Dicapai pada 2015-12-10.

doi.org

"Mapping of the human IL10 gene and further characterization of the 5' flanking sequence". Immunogenetics. 46 (2): 120–8. 1997. doi:10.1007/s002510050250. PMID 9162098.
"Interleukin-10: new perspectives on an old cytokine". Immunological Reviews. 226 (1): 205–18. December 2008. doi:10.1111/j.1600-065X.2008.00706.x. PMC 2724982. PMID 19161426.
"Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma". Structure. 3 (6): 591–601. June 1995. doi:10.1016/S0969-2126(01)00193-9. PMID 8590020.
"Interferon-λ: Immune Functions at Barrier Surfaces and Beyond". Immunity. 43 (1): 15–28. July 2015. doi:10.1016/j.immuni.2015.07.001. PMC 4527169. PMID 26200010.
"Interleukin-10 and related cytokines and receptors". Annual Review of Immunology. 22 (1): 929–79. 2004. doi:10.1146/annurev.immunol.22.012703.104622. PMID 15032600.
"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection". Nature Medicine. 16 (4): 452–9. April 2010. doi:10.1038/nm.2106. PMC 4229134. PMID 20208540.
Ağaç, Didem; Estrada, Leonardo D.; Maples, Robert; Hooper, Lora V.; Farrar, J. David (November 2018). "The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion". Brain, Behavior, and Immunity. 74: 176–185. doi:10.1016/j.bbi.2018.09.004. ISSN 1090-2139. PMC 6289674. PMID 30195028.
Saroz, Yurii; Kho, Dan T.; Glass, Michelle; Graham, Euan Scott; Grimsey, Natasha Lillia (2019-10-19). "Cannabinoid Receptor 2 (CB 2 ) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes". ACS Pharmacology & Translational Science (dalam bahasa Inggeris). 2 (6): 414–428. doi:10.1021/acsptsci.9b00049. ISSN 2575-9108. PMC 7088898. PMID 32259074.
"IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines". PLOS ONE. 7 (3): e33628. March 2012. Bibcode:2012PLoSO...733628L. doi:10.1371/journal.pone.0033628. PMC 3306427. PMID 22438968.
"The regulation of IL-10 production by immune cells". Nature Reviews. Immunology. 10 (3): 170–81. March 2010. doi:10.1038/nri2711. PMID 20154735. |hdl-access= requires |hdl= (bantuan)
"Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10". European Journal of Immunology. 35 (10): 2991–3001. October 2005. doi:10.1002/eji.200526192. PMID 16184516.
"Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region". Journal of Immunology. 165 (1): 292–6. July 2000. doi:10.4049/jimmunol.165.1.292. PMID 10861064.
"Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family". The EMBO Journal. 30 (10): 1977–89. May 2011. doi:10.1038/emboj.2011.94. PMC 3098495. PMID 21468030.
"Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a". Proceedings of the National Academy of Sciences of the United States of America. 106 (14): 5761–6. April 2009. Bibcode:2009PNAS..106.5761S. doi:10.1073/pnas.0808743106. PMC 2659714. PMID 19307576.
"Interleukin-10 and the interleukin-10 receptor". Annual Review of Immunology. 19 (1): 683–765. 2001-01-01. doi:10.1146/annurev.immunol.19.1.683. PMID 11244051.
"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes". The Journal of Experimental Medicine. 174 (5): 1209–20. November 1991. doi:10.1084/jem.174.5.1209. PMC 2119001. PMID 1940799.
"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression". The Journal of Experimental Medicine. 174 (4): 915–24. October 1991. doi:10.1084/jem.174.4.915. PMC 2118975. PMID 1655948.
"A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding". FASEB Journal. 14 (12): 1666–8. September 2000. doi:10.1096/fj.99-0874fje. PMID 10973911.
"IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway". European Journal of Immunology. 30 (6): 1683–90. June 2000. doi:10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A. PMID 10898505.
"Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep". Journal of Neuroimmunology. 60 (1–2): 165–8. July 1995. doi:10.1016/0165-5728(95)00066-b. PMID 7642744.
"Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10". Journal of Immunology. 160 (12): 5936–44. June 1998. doi:10.4049/jimmunol.160.12.5936. PMID 9637507.
"Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice". Infection and Immunity. 69 (9): 5249–63. September 2001. doi:10.1128/iai.69.9.5249-5263.2001. PMC 98633. PMID 11500393.
"Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism". The Journal of Experimental Medicine. 184 (2): 579–84. August 1996. doi:10.1084/jem.184.2.579. PMC 2192723. PMID 8760811.
"Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors". International Journal of Cancer. 80 (4): 624–9. February 1999. doi:10.1002/(sici)1097-0215(19990209)80:4<624::aid-ijc23>3.0.co;2-9. PMID 9935167.
"Essential role of nitric oxide and interferon-gamma for tumor immunotherapy with interleukin-10". Journal of Immunotherapy. 23 (2): 208–14. 2000-04-01. doi:10.1097/00002371-200003000-00005. PMID 10746547.
"A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells". Journal of Immunology. 162 (3): 1723–9. February 1999. doi:10.4049/jimmunol.162.3.1723. PMID 9973435.
"Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ". Blood. 98 (7): 2143–51. October 2001. doi:10.1182/blood.v98.7.2143. PMID 11568001.
"Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice". Journal of Immunology. 157 (1): 231–8. July 1996. doi:10.4049/jimmunol.157.1.231. PMID 8683120.
"IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs". Cancer Research. 72 (14): 3570–81. July 2012. doi:10.1158/0008-5472.CAN-12-0721. PMID 22581824.
"IL-10 elicits IFNγ-dependent tumor immune surveillance". Cancer Cell. 20 (6): 781–96. December 2011. doi:10.1016/j.ccr.2011.11.003. PMID 22172723.
"The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells". Journal of Interferon & Cytokine Research. 35 (12): 948–55. December 2015. doi:10.1089/jir.2014.0221. PMID 26309093.
"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B". Nature Immunology. 8 (10): 1095–104. October 2007. doi:10.1038/ni1503. PMID 17767162.
"Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age". Experimental Gerontology. 48 (2): 128–35. February 2013. doi:10.1016/j.exger.2012.11.001. PMC 3744178. PMID 23159957.
"Physical activity and plasma interleukin-6 in humans--effect of intensity of exercise". European Journal of Applied Physiology. 83 (6): 512–5. December 2000. doi:10.1007/s004210000312. PMID 11192058.
"Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans". The Journal of Physiology. 515 (1): 287–91. February 1999. doi:10.1111/j.1469-7793.1999.287ad.x. PMC 2269132. PMID 9925898.
"Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment". Scandinavian Journal of Immunology. 49 (5): 554–61. May 1999. doi:10.1046/j.1365-3083.1999.00546.x. PMID 10320650.
"Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism". European Journal of Immunology. 38 (4): 1106–17. April 2008. doi:10.1002/eji.200737821. PMID 18383040.
"Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy". Clinical Reviews in Allergy & Immunology. 42 (1): 26–34. February 2012. doi:10.1007/s12016-011-8287-6. PMID 22189514.
"Interleukin 10 decreases MICA expression on melanoma cell surface". Immunology and Cell Biology. 89 (3): 447–57. March 2011. doi:10.1038/icb.2010.100. PMID 20714339. |hdl-access= requires |hdl= (bantuan)
"Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients". Cytokine. 138: 155351. February 2021. doi:10.1016/j.cyto.2020.155351. ISSN 1043-4666. PMID 33127257.
"Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36". Brain Behav Immun. 94: 437–457. May 2021. doi:10.1016/j.bbi.2021.02.001. PMC 8058329. PMID 33588074.
"Interleukin-10 deficiency aggravates traumatic brain injury in male but not female mice". Exp Neurol. 355: 114125. September 2022. doi:10.1016/j.expneurol.2022.114125. PMID 35644427 Check |pmid= value (bantuan).
"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease". Clinical Gastroenterology and Hepatology. 4 (6): 754–9. June 2006. doi:10.1016/j.cgh.2006.03.028. PMID 16716759.
"Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group". Gastroenterology. 119 (6): 1473–82. December 2000. doi:10.1053/gast.2000.20229. PMID 11113068.
"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group". Gastroenterology. 119 (6): 1461–72. December 2000. doi:10.1053/gast.2000.20196. PMID 11113067.
"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group". Gastroenterology. 113 (2): 383–9. August 1997. doi:10.1053/gast.1997.v113.pm9247454. PMID 9247454.
"Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial". Archives of Dermatology. 135 (2): 187–92. February 1999. doi:10.1001/archderm.135.2.187. PMID 10052405.
"Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10". Archives of Dermatology. 138 (10): 1341–6. October 2002. doi:10.1001/archderm.138.10.1341. PMID 12374540.
"Proinflammatory effects of IL-10 during human endotoxemia". Journal of Immunology. 165 (5): 2783–9. September 2000. doi:10.4049/jimmunol.165.5.2783. PMID 10946310.
"Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma". Gut. 50 (2): 191–5. February 2002. doi:10.1136/gut.50.2.191. PMC 1773093. PMID 11788558.
"A receptor for interleukin 10 is related to interferon receptors". Proceedings of the National Academy of Sciences of the United States of America. 90 (23): 11267–71. December 1993. Bibcode:1993PNAS...9011267H. doi:10.1073/pnas.90.23.11267. PMC 47963. PMID 8248239.
"Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site". Immunity. 15 (1): 35–46. July 2001. doi:10.1016/S1074-7613(01)00169-8. PMID 11485736.
"Characterization of recombinant extracellular domain of human interleukin-10 receptor". The Journal of Biological Chemistry. 270 (21): 12906–11. May 1995. doi:10.1074/jbc.270.21.12906. PMID 7759550.
"Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1". Acta Crystallographica Section D. 57 (Pt 12): 1908–11. December 2001. Bibcode:2001AcCrD..57.1908J. doi:10.1107/S0907444901016249. PMID 11717514.
"Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization". European Journal of Biochemistry. 262 (1): 134–41. May 1999. doi:10.1046/j.1432-1327.1999.00363.x. PMID 10231374.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000136634 - Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

"IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines". PLOS ONE. 7 (3): e33628. March 2012. Bibcode:2012PLoSO...733628L. doi:10.1371/journal.pone.0033628. PMC 3306427. PMID 22438968.
"Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a". Proceedings of the National Academy of Sciences of the United States of America. 106 (14): 5761–6. April 2009. Bibcode:2009PNAS..106.5761S. doi:10.1073/pnas.0808743106. PMC 2659714. PMID 19307576.
"A receptor for interleukin 10 is related to interferon receptors". Proceedings of the National Academy of Sciences of the United States of America. 90 (23): 11267–71. December 1993. Bibcode:1993PNAS...9011267H. doi:10.1073/pnas.90.23.11267. PMC 47963. PMID 8248239.
"Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1". Acta Crystallographica Section D. 57 (Pt 12): 1908–11. December 2001. Bibcode:2001AcCrD..57.1908J. doi:10.1107/S0907444901016249. PMID 11717514.

immuno-oncologynews.com

Early Data Supports Phase 3 Trial of Pegilodecakin as Possible Treatment for Advanced Pancreatic Cancer

jimmunol.org

"Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10". Journal of Immunology. 160 (12): 5936–44. June 1998. doi:10.4049/jimmunol.160.12.5936. PMID 9637507.

nih.gov

pubmed.ncbi.nlm.nih.gov

"Mapping of the human IL10 gene and further characterization of the 5' flanking sequence". Immunogenetics. 46 (2): 120–8. 1997. doi:10.1007/s002510050250. PMID 9162098.
"Interleukin-10: new perspectives on an old cytokine". Immunological Reviews. 226 (1): 205–18. December 2008. doi:10.1111/j.1600-065X.2008.00706.x. PMC 2724982. PMID 19161426.
"Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma". Structure. 3 (6): 591–601. June 1995. doi:10.1016/S0969-2126(01)00193-9. PMID 8590020.
"Interferon-λ: Immune Functions at Barrier Surfaces and Beyond". Immunity. 43 (1): 15–28. July 2015. doi:10.1016/j.immuni.2015.07.001. PMC 4527169. PMID 26200010.
"Interleukin-10 and related cytokines and receptors". Annual Review of Immunology. 22 (1): 929–79. 2004. doi:10.1146/annurev.immunol.22.012703.104622. PMID 15032600.
"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection". Nature Medicine. 16 (4): 452–9. April 2010. doi:10.1038/nm.2106. PMC 4229134. PMID 20208540.
Ağaç, Didem; Estrada, Leonardo D.; Maples, Robert; Hooper, Lora V.; Farrar, J. David (November 2018). "The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion". Brain, Behavior, and Immunity. 74: 176–185. doi:10.1016/j.bbi.2018.09.004. ISSN 1090-2139. PMC 6289674. PMID 30195028.
Saroz, Yurii; Kho, Dan T.; Glass, Michelle; Graham, Euan Scott; Grimsey, Natasha Lillia (2019-10-19). "Cannabinoid Receptor 2 (CB 2 ) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes". ACS Pharmacology & Translational Science (dalam bahasa Inggeris). 2 (6): 414–428. doi:10.1021/acsptsci.9b00049. ISSN 2575-9108. PMC 7088898. PMID 32259074.
"IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines". PLOS ONE. 7 (3): e33628. March 2012. Bibcode:2012PLoSO...733628L. doi:10.1371/journal.pone.0033628. PMC 3306427. PMID 22438968.
"The regulation of IL-10 production by immune cells". Nature Reviews. Immunology. 10 (3): 170–81. March 2010. doi:10.1038/nri2711. PMID 20154735. |hdl-access= requires |hdl= (bantuan)
"Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10". European Journal of Immunology. 35 (10): 2991–3001. October 2005. doi:10.1002/eji.200526192. PMID 16184516.
"Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region". Journal of Immunology. 165 (1): 292–6. July 2000. doi:10.4049/jimmunol.165.1.292. PMID 10861064.
"Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family". The EMBO Journal. 30 (10): 1977–89. May 2011. doi:10.1038/emboj.2011.94. PMC 3098495. PMID 21468030.
"Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a". Proceedings of the National Academy of Sciences of the United States of America. 106 (14): 5761–6. April 2009. Bibcode:2009PNAS..106.5761S. doi:10.1073/pnas.0808743106. PMC 2659714. PMID 19307576.
"Interleukin-10 and the interleukin-10 receptor". Annual Review of Immunology. 19 (1): 683–765. 2001-01-01. doi:10.1146/annurev.immunol.19.1.683. PMID 11244051.
"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes". The Journal of Experimental Medicine. 174 (5): 1209–20. November 1991. doi:10.1084/jem.174.5.1209. PMC 2119001. PMID 1940799.
"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression". The Journal of Experimental Medicine. 174 (4): 915–24. October 1991. doi:10.1084/jem.174.4.915. PMC 2118975. PMID 1655948.
"A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding". FASEB Journal. 14 (12): 1666–8. September 2000. doi:10.1096/fj.99-0874fje. PMID 10973911.
"IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway". European Journal of Immunology. 30 (6): 1683–90. June 2000. doi:10.1002/1521-4141(200006)30:6<1683::AID-IMMU1683>3.0.CO;2-A. PMID 10898505.
"Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep". Journal of Neuroimmunology. 60 (1–2): 165–8. July 1995. doi:10.1016/0165-5728(95)00066-b. PMID 7642744.
"Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10". Journal of Immunology. 160 (12): 5936–44. June 1998. doi:10.4049/jimmunol.160.12.5936. PMID 9637507.
"Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice". Infection and Immunity. 69 (9): 5249–63. September 2001. doi:10.1128/iai.69.9.5249-5263.2001. PMC 98633. PMID 11500393.
"Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism". The Journal of Experimental Medicine. 184 (2): 579–84. August 1996. doi:10.1084/jem.184.2.579. PMC 2192723. PMID 8760811.
"Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors". International Journal of Cancer. 80 (4): 624–9. February 1999. doi:10.1002/(sici)1097-0215(19990209)80:4<624::aid-ijc23>3.0.co;2-9. PMID 9935167.
"Essential role of nitric oxide and interferon-gamma for tumor immunotherapy with interleukin-10". Journal of Immunotherapy. 23 (2): 208–14. 2000-04-01. doi:10.1097/00002371-200003000-00005. PMID 10746547.
"A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells". Journal of Immunology. 162 (3): 1723–9. February 1999. doi:10.4049/jimmunol.162.3.1723. PMID 9973435.
"Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ". Blood. 98 (7): 2143–51. October 2001. doi:10.1182/blood.v98.7.2143. PMID 11568001.
"Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice". Journal of Immunology. 157 (1): 231–8. July 1996. doi:10.4049/jimmunol.157.1.231. PMID 8683120.
"IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs". Cancer Research. 72 (14): 3570–81. July 2012. doi:10.1158/0008-5472.CAN-12-0721. PMID 22581824.
"IL-10 elicits IFNγ-dependent tumor immune surveillance". Cancer Cell. 20 (6): 781–96. December 2011. doi:10.1016/j.ccr.2011.11.003. PMID 22172723.
"The Potentiation of IFN-γ and Induction of Cytotoxic Proteins by Pegylated IL-10 in Human CD8 T Cells". Journal of Interferon & Cytokine Research. 35 (12): 948–55. December 2015. doi:10.1089/jir.2014.0221. PMID 26309093.
"Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B". Nature Immunology. 8 (10): 1095–104. October 2007. doi:10.1038/ni1503. PMID 17767162.
"Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age". Experimental Gerontology. 48 (2): 128–35. February 2013. doi:10.1016/j.exger.2012.11.001. PMC 3744178. PMID 23159957.
"Physical activity and plasma interleukin-6 in humans--effect of intensity of exercise". European Journal of Applied Physiology. 83 (6): 512–5. December 2000. doi:10.1007/s004210000312. PMID 11192058.
"Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans". The Journal of Physiology. 515 (1): 287–91. February 1999. doi:10.1111/j.1469-7793.1999.287ad.x. PMC 2269132. PMID 9925898.
"Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment". Scandinavian Journal of Immunology. 49 (5): 554–61. May 1999. doi:10.1046/j.1365-3083.1999.00546.x. PMID 10320650.
"Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism". European Journal of Immunology. 38 (4): 1106–17. April 2008. doi:10.1002/eji.200737821. PMID 18383040.
"Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy". Clinical Reviews in Allergy & Immunology. 42 (1): 26–34. February 2012. doi:10.1007/s12016-011-8287-6. PMID 22189514.
"Interleukin 10 decreases MICA expression on melanoma cell surface". Immunology and Cell Biology. 89 (3): 447–57. March 2011. doi:10.1038/icb.2010.100. PMID 20714339. |hdl-access= requires |hdl= (bantuan)
"Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients". Cytokine. 138: 155351. February 2021. doi:10.1016/j.cyto.2020.155351. ISSN 1043-4666. PMID 33127257.
"Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36". Brain Behav Immun. 94: 437–457. May 2021. doi:10.1016/j.bbi.2021.02.001. PMC 8058329. PMID 33588074.
"Interleukin-10 deficiency aggravates traumatic brain injury in male but not female mice". Exp Neurol. 355: 114125. September 2022. doi:10.1016/j.expneurol.2022.114125. PMID 35644427 Check |pmid= value (bantuan).
"A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease". Clinical Gastroenterology and Hepatology. 4 (6): 754–9. June 2006. doi:10.1016/j.cgh.2006.03.028. PMID 16716759.
"Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group". Gastroenterology. 119 (6): 1473–82. December 2000. doi:10.1053/gast.2000.20229. PMID 11113068.
"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group". Gastroenterology. 119 (6): 1461–72. December 2000. doi:10.1053/gast.2000.20196. PMID 11113067.
"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group". Gastroenterology. 113 (2): 383–9. August 1997. doi:10.1053/gast.1997.v113.pm9247454. PMID 9247454.
"Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation". The Journal of Rheumatology. 30 (4): 648–51. April 2003. PMID 12672180.
"Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial". Archives of Dermatology. 135 (2): 187–92. February 1999. doi:10.1001/archderm.135.2.187. PMID 10052405.
"Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10". Archives of Dermatology. 138 (10): 1341–6. October 2002. doi:10.1001/archderm.138.10.1341. PMID 12374540.
"Proinflammatory effects of IL-10 during human endotoxemia". Journal of Immunology. 165 (5): 2783–9. September 2000. doi:10.4049/jimmunol.165.5.2783. PMID 10946310.
"Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma". Gut. 50 (2): 191–5. February 2002. doi:10.1136/gut.50.2.191. PMC 1773093. PMID 11788558.
"A receptor for interleukin 10 is related to interferon receptors". Proceedings of the National Academy of Sciences of the United States of America. 90 (23): 11267–71. December 1993. Bibcode:1993PNAS...9011267H. doi:10.1073/pnas.90.23.11267. PMC 47963. PMID 8248239.
"Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site". Immunity. 15 (1): 35–46. July 2001. doi:10.1016/S1074-7613(01)00169-8. PMID 11485736.
"Characterization of recombinant extracellular domain of human interleukin-10 receptor". The Journal of Biological Chemistry. 270 (21): 12906–11. May 1995. doi:10.1074/jbc.270.21.12906. PMID 7759550.
"Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1". Acta Crystallographica Section D. 57 (Pt 12): 1908–11. December 2001. Bibcode:2001AcCrD..57.1908J. doi:10.1107/S0907444901016249. PMID 11717514.
"Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization". European Journal of Biochemistry. 262 (1): 134–41. May 1999. doi:10.1046/j.1432-1327.1999.00363.x. PMID 10231374.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Interleukin-10: new perspectives on an old cytokine". Immunological Reviews. 226 (1): 205–18. December 2008. doi:10.1111/j.1600-065X.2008.00706.x. PMC 2724982. PMID 19161426.
"Interferon-λ: Immune Functions at Barrier Surfaces and Beyond". Immunity. 43 (1): 15–28. July 2015. doi:10.1016/j.immuni.2015.07.001. PMC 4527169. PMID 26200010.
"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection". Nature Medicine. 16 (4): 452–9. April 2010. doi:10.1038/nm.2106. PMC 4229134. PMID 20208540.
Ağaç, Didem; Estrada, Leonardo D.; Maples, Robert; Hooper, Lora V.; Farrar, J. David (November 2018). "The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion". Brain, Behavior, and Immunity. 74: 176–185. doi:10.1016/j.bbi.2018.09.004. ISSN 1090-2139. PMC 6289674. PMID 30195028.
Saroz, Yurii; Kho, Dan T.; Glass, Michelle; Graham, Euan Scott; Grimsey, Natasha Lillia (2019-10-19). "Cannabinoid Receptor 2 (CB 2 ) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes". ACS Pharmacology & Translational Science (dalam bahasa Inggeris). 2 (6): 414–428. doi:10.1021/acsptsci.9b00049. ISSN 2575-9108. PMC 7088898. PMID 32259074.
"IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines". PLOS ONE. 7 (3): e33628. March 2012. Bibcode:2012PLoSO...733628L. doi:10.1371/journal.pone.0033628. PMC 3306427. PMID 22438968.
"Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family". The EMBO Journal. 30 (10): 1977–89. May 2011. doi:10.1038/emboj.2011.94. PMC 3098495. PMID 21468030.
"Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a". Proceedings of the National Academy of Sciences of the United States of America. 106 (14): 5761–6. April 2009. Bibcode:2009PNAS..106.5761S. doi:10.1073/pnas.0808743106. PMC 2659714. PMID 19307576.
"Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes". The Journal of Experimental Medicine. 174 (5): 1209–20. November 1991. doi:10.1084/jem.174.5.1209. PMC 2119001. PMID 1940799.
"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression". The Journal of Experimental Medicine. 174 (4): 915–24. October 1991. doi:10.1084/jem.174.4.915. PMC 2118975. PMID 1655948.
"Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice". Infection and Immunity. 69 (9): 5249–63. September 2001. doi:10.1128/iai.69.9.5249-5263.2001. PMC 98633. PMID 11500393.
"Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism". The Journal of Experimental Medicine. 184 (2): 579–84. August 1996. doi:10.1084/jem.184.2.579. PMC 2192723. PMID 8760811.
"Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age". Experimental Gerontology. 48 (2): 128–35. February 2013. doi:10.1016/j.exger.2012.11.001. PMC 3744178. PMID 23159957.
"Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans". The Journal of Physiology. 515 (1): 287–91. February 1999. doi:10.1111/j.1469-7793.1999.287ad.x. PMC 2269132. PMID 9925898.
"Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36". Brain Behav Immun. 94: 437–457. May 2021. doi:10.1016/j.bbi.2021.02.001. PMC 8058329. PMID 33588074.
"Entrez Gene: IL10 interleukin 10".
"Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma". Gut. 50 (2): 191–5. February 2002. doi:10.1136/gut.50.2.191. PMC 1773093. PMID 11788558.
"A receptor for interleukin 10 is related to interferon receptors". Proceedings of the National Academy of Sciences of the United States of America. 90 (23): 11267–71. December 1993. Bibcode:1993PNAS...9011267H. doi:10.1073/pnas.90.23.11267. PMC 47963. PMID 8248239.

sciencedirect.com

"Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients". Cytokine. 138: 155351. February 2021. doi:10.1016/j.cyto.2020.155351. ISSN 1043-4666. PMID 33127257.

unc.edu

cdr.lib.unc.edu

"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group". Gastroenterology. 119 (6): 1461–72. December 2000. doi:10.1053/gast.2000.20196. PMID 11113067.

uva.nl

dare.uva.nl

"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group". Gastroenterology. 113 (2): 383–9. August 1997. doi:10.1053/gast.1997.v113.pm9247454. PMID 9247454.

web.archive.org

Infante, Jeffrey R.; Naing, Aung; Papadopoulos, Kyriakos P.; Autio, Karen A.; Ott, Patrick Alexander; Wong, Deborah Jean Lee; Falchook, Gerald Steven; Patel, Manish R.; Pant, Shubham (2015-05-20). "A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors". ASCO Meeting Abstracts. 33 (15_suppl): 3017. Diarkibkan daripada yang asal pada 2015-12-22. Dicapai pada 2015-12-10.

wikipedia.org

en.wikipedia.org

"The regulation of IL-10 production by immune cells". Nature Reviews. Immunology. 10 (3): 170–81. March 2010. doi:10.1038/nri2711. PMID 20154735. |hdl-access= requires |hdl= (bantuan)
"Interleukin 10 decreases MICA expression on melanoma cell surface". Immunology and Cell Biology. 89 (3): 447–57. March 2011. doi:10.1038/icb.2010.100. PMID 20714339. |hdl-access= requires |hdl= (bantuan)
"Interleukin-10 deficiency aggravates traumatic brain injury in male but not female mice". Exp Neurol. 355: 114125. September 2022. doi:10.1016/j.expneurol.2022.114125. PMID 35644427 Check |pmid= value (bantuan).

worldcat.org

Ağaç, Didem; Estrada, Leonardo D.; Maples, Robert; Hooper, Lora V.; Farrar, J. David (November 2018). "The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion". Brain, Behavior, and Immunity. 74: 176–185. doi:10.1016/j.bbi.2018.09.004. ISSN 1090-2139. PMC 6289674. PMID 30195028.
Saroz, Yurii; Kho, Dan T.; Glass, Michelle; Graham, Euan Scott; Grimsey, Natasha Lillia (2019-10-19). "Cannabinoid Receptor 2 (CB 2 ) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes". ACS Pharmacology & Translational Science (dalam bahasa Inggeris). 2 (6): 414–428. doi:10.1021/acsptsci.9b00049. ISSN 2575-9108. PMC 7088898. PMID 32259074.
"Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients". Cytokine. 138: 155351. February 2021. doi:10.1016/j.cyto.2020.155351. ISSN 1043-4666. PMID 33127257.